Related references
Note: Only part of the references are listed.The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3
Rogier J. N. T. M. Litjens et al.
HUMAN PATHOLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
K. Miriam Elfstrom et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Type-Specific Detection of 30 Oncogenic Human Papillomaviruses by Genotyping both E6 and L1 Genes
Junping Peng et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial
Francesca Carozzi et al.
LANCET ONCOLOGY (2013)
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
Davit Bzhalava et al.
VIROLOGY (2013)
The 2010 Global Proficiency Study of Human Papillomavirus Genotyping in Vaccinology
Carina Eklund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Modeling Preventative Strategies against Human Papillomavirus-Related Disease in Developed Countries
Karen Canfell et al.
VACCINE (2012)
Global Burden of Human Papillomavirus and Related Diseases
David Forman et al.
VACCINE (2012)
A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study
Mark Schiffman et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)
Gina S. Ogilvie et al.
BMC CANCER (2010)
Prospective Study of Human Papillomavirus (HPV) Types, HPV Persistence, and Risk of Squamous Cell Carcinoma of the Cervix
Karin Sundstrom et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Prospective study of human papillomavirus and risk of cervical adenocarcinoma
Lisen Arnheim Dahlstrom et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Global Proficiency Study of Human Papillomavirus Genotyping
Carina Eklund et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
Anna Soederlund-Strand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial
A. Sargent et al.
BRITISH JOURNAL OF CANCER (2008)
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
V. M. H. Coupe et al.
BRITISH JOURNAL OF CANCER (2008)
Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland
Maarit Leinonen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
Marie-Helene Mayrand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Population-based study of screening test performance indices of three human papillomavirus DNA tests
Cecilia Wahlstrom et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
HPV type-specific risks of high-grade CIN during 4 years of follow-up:: A population-based prospective study
P. Naucler et al.
BRITISH JOURNAL OF CANCER (2007)
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial
Guglielmo Ronco et al.
LANCET ONCOLOGY (2006)
Bead-based multiplex genotyping of human papillomaviruses
M Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
L Kotaniemi-Talonen et al.
BRITISH JOURNAL OF CANCER (2005)
Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence
K Elfgren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women
NWJ Bulkmans et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women
O Forslund et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Estimates of cancer incidence and mortality in Europe in 1995
F Bray et al.
EUROPEAN JOURNAL OF CANCER (2002)
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review
K Nanda et al.
ANNALS OF INTERNAL MEDICINE (2000)
Share Paper
